Lexeo Therapeutics, Inc. LXEO
2.87 USD -0.04 (-1.37%)
Regular-session close
2.93 +0.06 +2.09%
After hours · Nov 13, 5:36 PM ET
2.77 Day range 2.95
2.63 52-week range 10.63
- YTD
- -71.10%
- 1 year
- -68.08%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -109.26M | -105.77M | -68.51M | -60.51M | -50.64M | |
| -99.96M | -98.33M | -66.39M | -59.28M | -50.62M | |
| -1.86 | -3.09 | -12.40 | -36.36 | -32.60 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 66.25M | 38.27M | 124.72M | 80.59M | 135.86M | |
| 268.69M | 146.94M | 139.81M | 97.08M | 136.86M | |
| 22.02M | 30.10M | 26.27M | 25.00M | 7.45M | |
| 7.89M | 9.92M | 11.64M | 13.48M | 0 | |
| 246.67M | 116.84M | 113.53M | -112.95M | -55.60M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -98.56M | -81.15M | -59.50M | -54.56M | -44.18M | |
| -90.25M | -94.08M | -165.00K | -901.00K | -188.00K | |
| 216.79M | 88.78M | 103.79M | 189.00K | 150.86M | |
| -397.00K | -481.00K | -115.00K | -672.00K | -188.00K | |
| 27.98M | -86.45M | 44.13M | -55.27M | 106.49M |